An adult HIV patient with unilateral Moyamoya syndrome

Clinical Neurology and Neurosurgery

Volumn 112, Issue 1, 2010, Pages 76-78

  Galati, V ^a   Grilli, E ^a   Sallustio, F ^b   Petrosillo, N ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antiretroviral therapy; Cerebrovascular disease; HIV; Ischemic stroke; Moyamoya; Unilateral involvement

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; EFAVIRENZ; LAMIVUDINE; TENOFOVIR; TICLOPIDINE; WARFARIN;

ANTICOAGULANT THERAPY; ANTIVIRAL THERAPY; ARTERY CALCIFICATION; ARTICLE; ASTHENIA; BRAIN ISCHEMIA; CAROTID ARTERY DISEASE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; DYSTONIA; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY FUNCTION; LEUKOENCEPHALOPATHY; LIVER FUNCTION; MALE; MOYAMOYA DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PARESTHESIA; PHYSICAL EXAMINATION; POSTERIOR CEREBRAL ARTERY; SEROLOGY; TACHYCARDIA;

AGED; CD4 LYMPHOCYTE COUNT; CEREBRAL ANGIOGRAPHY; HIV INFECTIONS; HUMANS; MALE; MOYAMOYA DISEASE; PARESTHESIA;

EID: 71649111056     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.09.002     Document Type: Article

References (16)

1. Suzuki J., and Takaku A. Cerebrovascular moyamoya" disease, disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 (1969) 288-299
2. Kuroda S., Ishikawa T., Houkin K., and Iwasaki Y. Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease. No Shinkei Geka 30 (2002) 1295-1300
3. Kuroda S., and Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7 (2008) 1056-1066
4. Scott R.M., and Smith E.R. Moyamoya disease and Moyamoya syndrome. N Engl J Med 360 (2009) 1226-1237
5. Suzuki J., and Kodama N. Moyamoya disease-a review. Stroke 14 (1983) 104-109
6. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMRW Recomm Rep 1992;18(December);41(RR-17):1-19.
7. Morgello S., and Laufer H. Quaternary neurosyphilis in a Haitian man with human immunodeficiency virus infection. Hum Pathol 20 8 (1989) 808-811
8. Sharfstein S.R., Ahmed S., Islam M.Q., Najjar M.I., and Ratushny V. Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome. J Stroke Cerebrovasc Dis 16 November-December (2007) 268-272
9. Hsiung G.Y., and Sotero de Menezes M. Moyamoya syndrome in a patient with congenital human immunodeficiency virus infection. J Child Neurol 14 April (4) (1999) 268-270
10. Kelly M.E., Bell-Stephens T.E., Marks M.P., Do H.M., and Steinberg G.K. Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis 22 2-3 (2006) 109-115 [Epub 9 May 2006]
11. Yamada H., Deguchi K., Tanigawara T., Takenaka K., Nishimura Y., Shinoda J., et al. The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 99 (1997) S24-S221
12. Rappaport J., Joseph J., Croul S., Alexander G., Del Valle L., Amini S., et al. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein. Tat J Leukoc Biol 65 April (4) (1999) 458-465
13. Melendez M.M., McNurlan M.A., Mynarcik D.C., Khan S., and Gelato M.C. Endothelial adhesion molecules are associated with inflammation in subjects with HIV disease. CID 46 (2008) 775-780
14. Sklar P., and Masur H. HIV infection and cardiovascular disease- Is there a really link?. N Engl J Med 349 (2003) 2065-2067
15. Monsuez J.J., Charniot J.C., Escaut L., Teicher E., Wyplosz B., Couzigou C., et al. HIV-associated vascular diseases: structural and functional changes, clinical implications. Int J Cardiol 133 (2009) 293-306 [Epub 7 Jan 2009]
16. Bozzette S.A., Ake C.F., Tam H.K., Chang S.W., and Louis T.A. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348 (2003) 702-710